Allergan PLC、純利益率、長期トレンド計算

	純利益率	=	100	×	株主に帰属する当期純利益(損失)¹	÷	純売上高¹
2019/12/31	-32.76%	=	100	×	(5,271,000)	÷	16,088,900)
2018/12/31	-32.28%	=	100	×	(5,096,400)	÷	15,787,400)
2017/12/31	-25.88%	=	100	×	(4,125,500)	÷	15,940,700)
2016/12/31	102.76%	=	100	×	14,973,400)	÷	14,570,600)
2015/12/31	25.98%	=	100	×	3,915,200)	÷	15,071,000)
2014/12/31	-12.48%	=	100	×	(1,630,500)	÷	13,062,300)
2013/12/31	-8.65%	=	100	×	(750,400)	÷	8,677,600)
2012/12/31	1.64%	=	100	×	97,300)	÷	5,914,900)
2011/12/31	5.69%	=	100	×	260,900)	÷	4,584,400)
2010/12/31	5.17%	=	100	×	184,400)	÷	3,566,900)
2009/12/31	7.95%	=	100	×	222,000)	÷	2,793,000)
2008/12/31	9.40%	=	100	×	238,379)	÷	2,535,501)
2007/12/31	5.65%	=	100	×	141,030)	÷	2,496,651)
2006/12/31	-22.48%	=	100	×	(445,005)	÷	1,979,244)
2005/12/31	8.40%	=	100	×	138,233)	÷	1,646,203)

¹ 千米ドル

Allergan PLC、純利益率、長期トレンド、競合他社との比較

	Allergan PLC	AbbVie Inc.	Amgen Inc.	Bristol-Myers Squibb Co.	Danaher Corp.	Eli Lilly & Co.	Gilead Sciences Inc.	Johnson & Johnson	Merck & Co. Inc.	Moderna Inc.	Pfizer Inc.	Regeneron Pharmaceuticals Inc.	Thermo Fisher Scientific Inc.
2019/12/31	-32.76%	23.69%	35.32%	13.15%	16.80%	37.27%	24.35%	18.42%	21.01%	—	31.45%	26.91%	14.47%
2018/12/31	-32.28%	17.36%	37.25%	21.81%	13.33%	13.16%	25.16%	18.75%	14.71%	—	20.79%	36.42%	12.06%
2017/12/31	-25.88%	18.82%	9.08%	4.85%	13.60%	-0.89%	18.03%	1.70%	5.97%	—	40.55%	20.41%	10.64%
2016/12/31	102.76%	23.22%	35.27%	22.94%	15.13%	12.90%	45.07%	23.01%	9.85%	—	13.66%	18.42%	11.06%
2015/12/31	25.98%	22.50%	33.13%	9.45%	16.33%	12.07%	56.32%	21.99%	11.25%	—	14.25%	15.50%	11.64%
2014/12/31	-12.48%	8.89%	26.69%	12.62%	13.05%	12.19%	49.44%	21.96%	28.22%	—	18.42%	12.34%	11.22%
2013/12/31	-8.65%	21.97%	27.93%	15.64%	14.10%	20.27%	28.46%	19.40%	10.00%	—	42.65%	20.16%	9.73%
2012/12/31	1.64%	28.70%	26.11%	11.12%	13.10%	18.09%	27.57%	16.14%	13.05%	—	24.70%	54.43%	9.42%
2011/12/31	5.69%	—	24.08%	17.46%	13.50%	17.90%	34.60%	14.87%	13.05%	—	14.84%	-49.74%	11.34%
2010/12/31	5.17%	—	31.56%	15.92%	13.58%	21.97%	39.26%	21.65%	1.87%	—	12.18%	-22.76%	9.60%
2009/12/31	7.95%	—	32.09%	56.42%	10.30%	19.82%	40.74%	19.82%	47.04%	—	17.27%	-17.88%	8.41%
2008/12/31	9.40%	—	28.57%	25.47%	10.38%	-10.17%	39.55%	20.31%	32.74%	—	16.78%	-34.69%	9.47%
2007/12/31	5.65%	—	22.12%	11.19%	12.42%	15.85%	43.27%	17.31%	13.54%	—	16.82%	-84.46%	7.81%
2006/12/31	-22.48%	—	21.29%	8.85%	11.69%	16.97%	-45.98%	20.73%	19.59%	—	39.98%	-161.30%	4.46%
2005/12/31	8.40%	—	30.56%	15.62%	11.24%	13.52%	44.99%	20.61%	21.04%	—	15.76%	-144.19%	8.48%

Allergan PLC、純利益率、長期トレンド、産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス

Allergan PLC、純利益率、長期トレンド、業界との比較: 医療

Allergan PLC (NYSE:AGN)

純利益率
2005年以降